Menu

Washington State University Researchers Complain of Industry Influence

Agriculture faculty members allege funding from industry organizations is tied to their employment status.

Nov 6, 2017
Kerry Grens

PIXABAY, FREE-PHOTOSThirty faculty members of Washington State University’s (WSU) Agriculture, Human and Natural Resources College say administrators there are bending to the influence of industry in setting research and employment priorities, according to the Capital Press. Two researchers who spoke with the news outlet describe career obstacles after losing funding from agriculture industry groups.

“The industry is dictating what to do. If the industry says, ‘We don’t like somebody,’ WSU has to comply,” Nnadozie Oraguzie, who was a researcher studying the propagation of sweet cherry trees at WSU until he resigned in 2016, tells the Capital Press. “They don’t want to lose the money they’re getting from industry.”

Ron Mittelhammer, the college’s dean, defended the faculty’s academic freedom to the Capital Press, stating that industry should not have the “only say.” He also said that if a researcher was deemed to be underperforming by the college, the reasons for that evaluation could include “issues with stakeholders,” but that that would not be the only reason.

The 30 faculty members made their concerns known to Donna Potts, WSU chapter president of the American Association of University Professors. “They do feel industry is calling all the shots,” she tells the Capital Press.

Kalvinder Gill, a wheat geneticist who held an endowed chair at WSU, says he lost the endowment after the Washington Grain Commission pulled his funding in 2014. College administrators “tried to push me out as hard as they could,” he tells the Capital Press. Both the Grain Commission and the Washington Tree Fruit Research Commission say they have no role in employment decisions by WSU.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.